Literature DB >> 27076403

Evaluation of Netrin-1 Levels and Albuminuria in Patients With Diabetes.

Emre Ay1, Kamile Marakoğlu2, Muhammet Kizmaz2, Ali Ünlü3.   

Abstract

BACKGROUND: Netrin-1 is a diagnostic biomarker that has been identified recently for chronic renal failure (CRF) in animal experiments. Netrin-1 levels in urine have been shown to have increased significantly at the acute kidney damage. Human studies on the relation between the CRF and plasma netrin-1 levels have not been found in the literature. This study aimed to investigate whether plasma netrin-1 levels increased in the early stages of the CRF in diabetic patients.
METHODS: Plasma samples from healthy volunteers and diabetic patients with and without microalbuminuria were collected after receiving consent. Netrin-1 in plasma was quantified by enzyme-linked immunosorbent assay and the data were analyzed to determine whether plasma netrin-1 correlates significantly with disease progression. RESULT: Plasma netrin-1 level in microalbuminuric diabetic patients was significantly higher than in normoalbuminuric diabetic patients and the control group. However, no significant difference between normoalbuminuric patients and control group was determined. Plasma netrin-1 level was significantly associated with albuminuria and estimated glomerular filtration rate, independently of age and sex.
CONCLUSION: This study supports that plasma netrin-1 level increases significantly when glomerular damage occurs in diabetic nephropathy.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  albuminuria; diabetic nephropathy; netrin-1

Mesh:

Substances:

Year:  2016        PMID: 27076403      PMCID: PMC6806737          DOI: 10.1002/jcla.21965

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  21 in total

1.  Renal Proximal Tubular Albumin Reabsorption: Daily Prevention of Albuminuria.

Authors:  Michael Gekle
Journal:  News Physiol Sci       Date:  1998-02

2.  Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

Authors:  Andrew S Levey; Kai-Uwe Eckardt; Yusuke Tsukamoto; Adeera Levin; Josef Coresh; Jerome Rossert; Dick De Zeeuw; Thomas H Hostetter; Norbert Lameire; Garabed Eknoyan
Journal:  Kidney Int       Date:  2005-06       Impact factor: 10.612

3.  Urinary netrin-1 is an early predictive biomarker of acute kidney injury after cardiac surgery.

Authors:  Ganesan Ramesh; Catherine D Krawczeski; Jessica G Woo; Yu Wang; Prasad Devarajan
Journal:  Clin J Am Soc Nephrol       Date:  2009-12-10       Impact factor: 8.237

4.  Hypoxia induces netrin-1 and Unc5b in atherosclerotic plaques: mechanism for macrophage retention and survival.

Authors:  Bhama Ramkhelawon; Yuan Yang; Janine M van Gils; Bernd Hewing; Katey J Rayner; Sajesh Parathath; Liang Guo; Scott Oldebeken; Jessica L Feig; Edward A Fisher; Kathryn J Moore
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-04-18       Impact factor: 8.311

5.  Netrin-1 and kidney injury. II. Netrin-1 is an early biomarker of acute kidney injury.

Authors:  W Brian Reeves; Osun Kwon; Ganesan Ramesh
Journal:  Am J Physiol Renal Physiol       Date:  2008-01-30

6.  Structural-functional relationships in diabetic nephropathy.

Authors:  S M Mauer; M W Steffes; E N Ellis; D E Sutherland; D M Brown; F C Goetz
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

Review 7.  The neuroimmune guidance cue netrin-1: a new therapeutic target in cardiovascular disease.

Authors:  Joseph Bertrand Bongo; Dao Quan Peng
Journal:  J Cardiol       Date:  2013-11-18       Impact factor: 3.159

8.  Impaired tubular uptake explains albuminuria in early diabetic nephropathy.

Authors:  Leileata M Russo; Ruben M Sandoval; Silvia B Campos; Bruce A Molitoris; Wayne D Comper; Dennis Brown
Journal:  J Am Soc Nephrol       Date:  2008-12-31       Impact factor: 10.121

9.  Protective role for netrin-1 during diabetic nephropathy.

Authors:  Eunyoung Tak; Douglas Ridyard; Alexander Badulak; Antasia Giebler; Uladzimir Shabeka; Tilmann Werner; Eric Clambey; Radu Moldovan; Michael A Zimmerman; Holger K Eltzschig; Almut Grenz
Journal:  J Mol Med (Berl)       Date:  2013-05-01       Impact factor: 4.599

10.  The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques.

Authors:  Janine M van Gils; Merran C Derby; Luciana R Fernandes; Bhama Ramkhelawon; Tathagat D Ray; Katey J Rayner; Sajesh Parathath; Emilie Distel; Jessica L Feig; Jacqueline I Alvarez-Leite; Alistair J Rayner; Thomas O McDonald; Kevin D O'Brien; Lynda M Stuart; Edward A Fisher; Adam Lacy-Hulbert; Kathryn J Moore
Journal:  Nat Immunol       Date:  2012-01-08       Impact factor: 25.606

View more
  5 in total

1.  Plasma circular RNA profiling of patients with gastric cancer and their droplet digital RT-PCR detection.

Authors:  Tianwen Li; Yongfu Shao; Liyun Fu; Yi Xie; Linwen Zhu; Weiliang Sun; Rui Yu; Bingxiu Xiao; Junming Guo
Journal:  J Mol Med (Berl)       Date:  2017-11-02       Impact factor: 4.599

Review 2.  Netrin as a Novel Biomarker and Its Therapeutic Implications in Diabetes Mellitus and Diabetes-Associated Complications.

Authors:  Ebrahim M Yimer; Kaleab Alemayehu Zewdie; Hailemichael Zeru Hishe
Journal:  J Diabetes Res       Date:  2018-09-18       Impact factor: 4.011

3.  Relationship Between Circulating Netrin-1 Concentration, Impaired Fasting Glucose, and Newly Diagnosed Type 2 Diabetes.

Authors:  Jisook Yim; Gyuri Kim; Byung-Wan Lee; Eun Seok Kang; Bong-Soo Cha; Jeong-Ho Kim; Jin Won Cho; Sang-Guk Lee; Yong-Ho Lee
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-23       Impact factor: 5.555

4.  Identification of a Novel Five-Gene Signature as a Prognostic and Diagnostic Biomarker in Colorectal Cancers.

Authors:  Souvik Ghatak; Syrina F Mehrabi; Lubna M Mehdawi; Shakti Ranjan Satapathy; Anita Sjölander
Journal:  Int J Mol Sci       Date:  2022-01-12       Impact factor: 5.923

5.  Serum netrin and VCAM-1 as biomarker for Egyptian patients with type IΙ diabetes mellitus.

Authors:  Maher M Fadel; Faten R Abdel Ghaffar; Shimaa K Zwain; Hany M Ibrahim; Eman Ae Badr
Journal:  Biochem Biophys Rep       Date:  2021-06-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.